Neurologic outcome and quality of life three months after COVID-19

Takeaway

  • Neurologic symptoms are common at 3-month follow-up despite recovery from acute coronavirus 2019 (COVID-19) infection.

Why this matters

  • Little is known about long-term neurologic or neuropsychiatric consequences of COVID-19; although the few available studies appear to indicate that some symptoms may linger for at least 3 months, particularly in patients with severe infection.

  • The prevalence of neurologic symptoms following COVID-19 recovery adds insight to longer-term sequelae of this disease, and may constitute a starting point for further ongoing studies of COVID-19 patients to assess neurologic symptom longevity and impact on quality of life.